GoodRx Care vs Shed: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Shed beats GoodRx Care overall, scoring 7.8/10 vs 6.2/10. GoodRx Care is more affordable at $119/mo vs $199/mo. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at marke. Choose Shed for users who want fast delivery and a streamlined compounded gl.

A side-by-side comparison of GoodRx Care and Shed covering pricing, scores, medication types, insurance, and more to help you decide.

GoodRx Care

#48 of 48

6.2/10

GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.

Visit GoodRx Care

Higher Rated

Shed

#17 of 48

7.8/10

Newer GLP-1 provider focused on speed and simplicity — fast approvals, fast shipping, and a clean user experience at a competitive price point.

Visit Shed

Feature	GoodRx Care	Shed
Our Score	6.2/10	7.8/10
Starting Price	$119/mo	$199/mo
Medication Type	Brand	Both
Insurance Accepted	Yes	No
Best For	Users who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing — $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pill	Users who want fast delivery and a streamlined compounded GLP-1 experience
Ranking	#48	#17

Pros & Cons Compared

GoodRx Care

Pros

+2026 subscription rewrite — $119/mo standard membership with medication priced among the lowest on the market
+Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
+Oral Wegovy pill available at $149-199/mo — one of the cheapest oral semaglutide routes
+Insurance accepted — GoodRx's integration with savings cards can stack with coverage

Cons

−Model changed from pay-per-visit to subscription — users expecting à-la-carte pricing should double-check current terms
−Compounded GLP-1s are de-emphasized on current marketing — may no longer be available
−Subscription model means ongoing monthly fee even in maintenance months
−Follow-up clinical care is still basic compared to dedicated GLP-1 platforms

Shed

Pros

+Industry-leading delivery speed — most patients receive medication within 2-3 days of enrollment
+$149/mo is competitively priced for an all-inclusive compounded program with good support
+Streamlined onboarding with no video call — approved and shipped faster than most competitors
+Clean, modern UX with real-time shipping tracking and easy provider messaging

Cons

−Compounded semaglutide and tirzepatide only — no brand-name options
−Newer company (founded 2024) with limited track record and outcome data
−No insurance billing and no FSA/HSA superbills currently available
−Clinical support is responsive but less proactive than premium platforms

Our Verdict

Shed edges out GoodRx Care with a score of 7.8/10 vs 6.2/10. If budget is your priority, GoodRx Care starts at $119/mo compared to Shed's $199/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. Shed offers both brand-name and compounded medications, giving you more flexibility. Choose GoodRx Care if you want: users who want fda-approved brand-name glp-1 access at market-leading subscription pricing — $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither GoodRx Care nor Shed feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review